CN101797304B - 一种调节女性阴道微生态的凝胶 - Google Patents
一种调节女性阴道微生态的凝胶 Download PDFInfo
- Publication number
- CN101797304B CN101797304B CN2010101327489A CN201010132748A CN101797304B CN 101797304 B CN101797304 B CN 101797304B CN 2010101327489 A CN2010101327489 A CN 2010101327489A CN 201010132748 A CN201010132748 A CN 201010132748A CN 101797304 B CN101797304 B CN 101797304B
- Authority
- CN
- China
- Prior art keywords
- gel
- vagina
- vaginas
- mass concentration
- microecology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001215 vagina Anatomy 0.000 title claims abstract description 62
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 32
- 229960001631 carbomer Drugs 0.000 claims abstract description 32
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 31
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 31
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 26
- 150000001746 carotenes Chemical class 0.000 claims abstract description 26
- 235000005473 carotenes Nutrition 0.000 claims abstract description 26
- 229940111630 tea tree oil Drugs 0.000 claims abstract description 26
- 239000010677 tea tree oil Substances 0.000 claims abstract description 26
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims abstract description 26
- 244000068988 Glycine max Species 0.000 claims description 57
- 235000010469 Glycine max Nutrition 0.000 claims description 57
- 230000001105 regulatory effect Effects 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 14
- 241000186660 Lactobacillus Species 0.000 abstract description 22
- 229940039696 lactobacillus Drugs 0.000 abstract description 21
- 206010046914 Vaginal infection Diseases 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 201000008100 Vaginitis Diseases 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 7
- 244000052769 pathogen Species 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 210000004877 mucosa Anatomy 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 235000018291 probiotics Nutrition 0.000 abstract description 4
- 239000006041 probiotic Substances 0.000 abstract description 3
- 108010082495 Dietary Plant Proteins Proteins 0.000 abstract description 2
- 239000006210 lotion Substances 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 230000003749 cleanliness Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000000470 constituent Substances 0.000 description 12
- 244000052616 bacterial pathogen Species 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229940011871 estrogen Drugs 0.000 description 8
- 239000000262 estrogen Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 230000008719 thickening Effects 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000036649 Dysbacteriosis Diseases 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 206010065954 Stubbornness Diseases 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000032159 Vaginal inflammation Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012627 chemopreventive agent Substances 0.000 description 1
- 229940124443 chemopreventive agent Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
效应 | F | P |
治疗组间 | 0.697 | 0.407 |
中心间 | 0.869 | 0.354 |
治疗前后 | 33.360 | <0.001 |
治疗与时间交互作用 | 8.567 | 0.005 |
中心与时间交互作用 | 4.081 | 0.047 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101327489A CN101797304B (zh) | 2010-03-23 | 2010-03-23 | 一种调节女性阴道微生态的凝胶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101327489A CN101797304B (zh) | 2010-03-23 | 2010-03-23 | 一种调节女性阴道微生态的凝胶 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101797304A CN101797304A (zh) | 2010-08-11 |
CN101797304B true CN101797304B (zh) | 2011-08-03 |
Family
ID=42593245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101327489A Active CN101797304B (zh) | 2010-03-23 | 2010-03-23 | 一种调节女性阴道微生态的凝胶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101797304B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520707B (zh) * | 2013-10-22 | 2015-08-19 | 易金阳 | 一种益菌治菌预防和治疗妇科生殖系统感染的组合物 |
CN104224923A (zh) * | 2014-07-07 | 2014-12-24 | 海南华拓天涯制药有限公司 | 治疗妇科阴道疾病的茶树精油抗菌凝胶 |
CN107184911A (zh) * | 2017-06-19 | 2017-09-22 | 太原谷歌医药科技有限公司 | 一种用于预防宫颈癌和治疗乳头瘤病毒(hpv)感染及阴道炎症的产品及制备方法 |
CN108066278B (zh) * | 2017-12-21 | 2020-05-08 | 广州润虹医药科技股份有限公司 | 一种含有壳寡糖的妇科用凝胶及其制备方法 |
CN108096327A (zh) * | 2017-12-29 | 2018-06-01 | 广州润虹医药科技股份有限公司 | 一种含有壳寡糖的妇科用栓剂及其制备方法 |
CN109589404A (zh) * | 2018-11-27 | 2019-04-09 | 杭州元研细胞生物科技有限公司 | 一种用于女性生殖系统抗衰修复产品及其制备方法 |
CN109395054A (zh) * | 2019-01-04 | 2019-03-01 | 赵显梁 | 一种抑菌紧致凝胶及其制备方法 |
CN110193004A (zh) * | 2019-04-28 | 2019-09-03 | 佛山市富馨科技实业有限公司 | 含生物抑菌肽的女性抑菌凝胶及其制备方法 |
CN111000795A (zh) * | 2019-12-26 | 2020-04-14 | 山西瑞博隆生物科技有限公司 | 含大豆异黄酮纳米微球的复方微乳凝胶及制备方法 |
CN113633757A (zh) * | 2021-09-09 | 2021-11-12 | 广东圆康再生医学科技开发有限公司 | 一种阴道黏膜修复组合物及其制备方法 |
CN114588253B (zh) * | 2022-04-27 | 2022-12-09 | 云南康旭生物科技有限公司 | 用于修复和预防阴道粘膜衰老的药物组合物及其制剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1520816A (zh) * | 2003-01-27 | 2004-08-18 | 上海海天医药科技开发有限公司 | 苦参总碱凝胶制剂及该凝胶制剂的制备方法 |
-
2010
- 2010-03-23 CN CN2010101327489A patent/CN101797304B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1520816A (zh) * | 2003-01-27 | 2004-08-18 | 上海海天医药科技开发有限公司 | 苦参总碱凝胶制剂及该凝胶制剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101797304A (zh) | 2010-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101797304B (zh) | 一种调节女性阴道微生态的凝胶 | |
CN111202822A (zh) | 一种妇科外用抗菌喷剂及其制备方法 | |
CN103041367B (zh) | 一种防治阴道炎的中药复方制剂及其制备方法 | |
CN101797269B (zh) | 一种调节女性阴道微生态的生理平衡液 | |
CN110447799A (zh) | 一种用于改善肠道菌群的复合固体植物饮料及其制备方法 | |
CN103157095B (zh) | 芸豆植物凝集素在制备人用药物中的应用及其药物组合物 | |
CN111759885A (zh) | 一种苦参组合物、苦参凝胶及其制备方法 | |
CN105685868A (zh) | 一种益生菌复配蔓越莓的女性生殖健康营养补充剂 | |
CN110859871A (zh) | 一种用于前列腺炎的组合物及其制备方法 | |
CN107184911A (zh) | 一种用于预防宫颈癌和治疗乳头瘤病毒(hpv)感染及阴道炎症的产品及制备方法 | |
CN103933363A (zh) | 一种伤口愈合膏及其制备方法 | |
CN103191408A (zh) | 一种治疗阴道炎的药物组合物、凝胶剂及其用途 | |
CN102743657A (zh) | 防治仔猪腹泻病的中药物组合物及其制备方法 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN107496767A (zh) | 一种用于女性私密处保养的益菌酵素及其制备方法 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
CN104547770A (zh) | 一种促进畜禽生长的发酵中药及其制备方法 | |
CN105999224A (zh) | 一种仿生型妇科洗液及其制备方法 | |
CN111184832A (zh) | 一种具有缩阴润滑、养巢护巢功能的植物益生菌组合物及其制备方法 | |
CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
CN110193004A (zh) | 含生物抑菌肽的女性抑菌凝胶及其制备方法 | |
CN115006312B (zh) | 一种抗炎抑菌组合物和应用及其含该组合物的制品和制备方法 | |
CN106177271A (zh) | 一种含有植物提取物的清洗护理液 | |
KR102513673B1 (ko) | 침향환 조성물의 제조 방법 | |
CN106581660A (zh) | 一种治疗微生物感染的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Taiyuan Jinbo Bio-Pharmaceutical Co.,Ltd. Assignor: Yang Xia Contract record no.: 2011990000879 Denomination of invention: Gel for adjusting microecology in vaginas of women Granted publication date: 20110803 License type: Exclusive License Open date: 20100811 Record date: 20110908 |
|
ASS | Succession or assignment of patent right |
Owner name: TAIYUAN JINBO BIOMEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YANG XIA Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 030001 TAIYUAN, SHAANXI PROVINCE TO: 030032 TAIYUAN, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee after: Taiyuan Jinbo Bio-Pharmaceutical Co.,Ltd. Address before: 030001 No. 59 Kangle West Street, Ankang District, 3, Shanxi, Taiyuan Patentee before: Yang Xia |
|
C56 | Change in the name or address of the patentee |
Owner name: SHANXI JINBO BIOLOGICAL PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: TAIYUAN JINBO BIOMEDICAL TECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee after: Shanxi Jin Bo Biomedics Inc. Address before: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee before: Taiyuan Jinbo Bio-Pharmaceutical Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 030032 No.18, Jinbo street, Tanghuai Park, Taiyuan comprehensive reform demonstration zone, Taiyuan City, Shanxi Province Patentee after: SHANXI JINBO BIOMEDICAL Co.,Ltd. Address before: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee before: SHANXI JINBO BIOMEDICAL Co.,Ltd. |